Salvia raises 26 million euros to finance migraine neurostimulation therapySalvia BioElectronics has raised 26 million euros ($30 million) in new financing to fund development of a neurostimulation Share XSalvia raises 26 million euros to finance migraine neurostimulation therapyhttps://pharmaphorum.com/news/salvia-raises-26-million-euros-to-finance-migraine-neurostimulation-therapy/
